HIGHLIGHTS
- who: Gloria Delfanti and collaborators from the a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy have published the research work: Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment, in the Journal: (JOURNAL)
SUMMARY
One of the iNKT_cell functional hallmarks is their avid autoreactivity upon recognition of stress-associated cell endogenous lipids. iNKT_cells undergo a distinct developmental pathway compared to T_cells, leading to the acquisition of innate effector functions already in the thymus. Thymic iNKT_cells indeed express markers usually . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.